268
Participants
Start Date
September 25, 2019
Primary Completion Date
October 7, 2020
Study Completion Date
October 28, 2020
Delafloxacin
Powder for solution for infusion 300 mg or tablet 450 mg, BID, for 5 to 14 days
Vancomycin
Powder for solution for infusion 15mg/kg, BID, for 5 to 14 days
Linezolid
Solution for infusion or tablet, 600 mg BID, for 5 to 14 days
Piperacillin/Tazobactam
Powder for solution for infusion 4/0.5 g, TID, for 5 to 14 days
Tigecycline
Powder for solution for infusion 50 mg, TID, for 5 to 14 days
Hospital Agostino Gemelli, Roma
Lead Sponsor
Menarini Group
INDUSTRY